Close to 20 companies are currently engaged in the discovery and development of RNA

Health & Safety / RNA Targeting Market, RNA targeting small molecules, RNA therapeutics market, RNA therapeutics market Size / By /

In recent years, RNA’s potential as a target molecule for small molecules has been widely recognized; a number of players have developed proprietary technologies for direct and indirect RNA targeting, to treat a wide range of clinical conditions

Advertisements

 

To order this 260+ page report, which features 110+ figures, please visit https://www.rootsanalysis.com/reports/rna-targeting-small-molecule-therapeutics-market.html

 

The USD 8.3 billion (by 2030) financial opportunity within the RNA targeting small molecules therapeutics market has been analyzed across the following segments:

  • Type of Target Disease Indication
  • Aniridia
  • Breast Cancer
  • Castrate-resistant Prostate Cancer
  • Colorectal Cancer
  • Cystic Fibrosis
  • Crohn’s Disease
  • Duchenne Muscular Dystrophy
  • Dravet Syndrome
  • HIV Infections
  • Impaired Renal Functions
  • NSCLC
  • Rheumatoid Arthritis
  • Spinal Muscular Atrophy
  • Ulcerative Colitis

 

  • Type of Therapeutic Area
  • Autoimmune Disorders
  • Genetic Disorders
  • Inflammatory Disorders
  • Infectious Disorders
  • Kidney Disorders
  • Neurological Disorders
  • Oncological Disorders
  • Ophthalmic Disorders
  • Rare Disorders
  • Respiratory Disorders

 

  • Type of Target Molecule
  • CDKL5
  • Cap Binding Complex
  • Dystrophin Protein
  • Estrogen Receptor Alpha
  • G542X
  • MNK1 / MNK2
  • PAX6 Gene
  • SMN2

 

  • Type of Approach
  • Indirect RNA Targeting- Epitranscriptomics
  • mRNA Translation Modulation
  • RNA Splicing Modification

 

  • Route of Administration
  • Oral
  • Subcutaneous

 

  • Key Geographical Regions
  • North America
  • Europe

 

 

Transcripts of interviews held with the following senior level representatives of stakeholder companies

The RNA Targeting Small Molecules Therapeutics Market report features the following companies, which we identified to be key players in this domain:

  • Abivax
  • AC Immune
  • Arrakis Therapeutics
  • eFFECTOR Therapeutics
  • ELOXX Pharmaceuticals
  • PTC Therapeutics
  • H3 Biomedicine
  • Ribometrix
  • Skyhawk Therapeutics
  • STORM Therapeutics

 

Table of Contents

 

  1. Preface

    2. Executive Summary

    3. Introduction

 

  1. Market Overview

  2. Company Competitiveness and Investment Landscape

 

  1. Company Profiles

  2. Recent Collaborations and Partnerships

 

  1. Funding and Investment Analysis

  2. Market Sizing and Opportunity Analysis

  3. Conclusion

  4. Executive Insights

  5. Appendix 1. Tabulated Data

 

  1. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/rna-targeting-small-molecule-therapeutics-market.html

 

Contact:

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

Related Posts